New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
06:58 EDTHASHasbro upgraded to Market Perform from Underperform at BMO Capital
BMO Capital downgraded Hasbro to reflect positive channel checks that indicate new product initiatives are gaining traction and management's focus on shareholder returns. Price target raised to $50 from $38.
News For HAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
10:01 EDTHASOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:38 EDTHASHasbro coverage resumed with a Buy at Goldman
Target $70.
November 18, 2014
11:46 EDTHASHasbro management to meet with Needham
Subscribe for More Information
November 17, 2014
16:24 EDTHASOn The Fly: Closing Wrap
Stocks on Wall Street were quiet and traded in a fairly narrow range for their sixth straight session, despite a "merger Monday" that saw over $100B in deals announced. The Dow and S&P, which began the week near record levels, passed back and forth across the flat line several times during the day, though the Nasdaq weakened early in the session and never really recovered. ECONOMIC EVENTS: In the U.S., industrial production fell 0.1% in October, missing expectations for it to have risen 0.2% from the prior month. October capacity utilization came in at 78.9%, which fell short of the expected 79.3% rate. The Empire State manufacturing index, which reflects manufacturing activity in the New York region, rose 4 points to 10.2 in November, which was generally in-line with the consensus forecast. In Asia, Japan's GDP unexpectedly shrank an annualized 1.6% last quarter, missing projections for a 2.2% gain and sinking its economy into a recession. COMPANY NEWS: Actavis (ACT) gained $4.17, or 1.71%, to $247.94 after confirming that it agreed to acquire Allergan (AGN) for a combination of $129.22 in cash and 0.3683 Actavis shares valued at approximately $66B, or $219 per Allergan share. Valeant Pharmaceuticals (VRX), which had been in a contentious fight to buy Allergan, commented that it "cannot justify to its own shareholders" paying a price of $219 or more per share for the Botox maker, whose stock rose $10.55, or 5.31%, to $209.20... Halliburton (HAL), conversely, fell $5.85, or 10.62%, to $49.23 after it agreed to acquire Baker Hughes (BHI) in a stock and cash transaction valued at $78.62 per Baker Hughes share, representing an enterprise value of $38B. When the deal talks were first reported by The Wall Street Journal last week, antitrust concerns were highlighted by analysts, but Halliburton said it had agreed to divest businesses that generate up to $7.5B in revenues, if required by regulators, and agreed to pay a fee of $3.5B if the transaction terminates due to a failure to obtain required approvals. Baker Hughes rose $5.34, or 8.92%, to $65.23 after the deal was announced. MAJOR MOVERS: Among the notable gainers was Celldex Therapeutics (CLDX), which advanced $4.09, or 28.88%, to $18.25 after the company reported it saw a statistically significant overall survival benefit, along with an increase in clinically meaningful tumor shrinkage, in a sub-group of its study of a drug to treat a specific type of brain tumor. Also higher was Amicus Therapeutics (FOLD), which rose $1.01, or 17.75%, to $6.70 after the company announced additional data on secondary endpoints from its second Phase 3 study of its treatment for Fabry disease. Among the noteworthy losers was William Lyon Homes (WLH), which fell $3.52, or 15.53%, to $19.14 after the company announced that it intends to offer, subject to market and other conditions, 1M tangible equity units, which will consist of a prepaid stock purchase contract and an amortizing note. Also lower were shares of DreamWorks (DWA), which dropped $3.71, or 14.26%, to $22.31 after multiple media outlets reported that talks about a takeover of the company by Hasbro (HAS) had ended. INDEXES: The Dow gained 13.01, or 0.07%, to 17,647.75, the Nasdaq lost 17.54, or 0.37%, to 4,671.00, and the S&P 500 added 1.50, or 0.07%, to 2,041.32.
12:27 EDTHASOn The Fly: Midday Wrap
Subscribe for More Information
10:10 EDTHASDreamWorks sinks, Hasbro rebounds after takeover talks reportedly end
Shares of movie maker DreamWorks (DWA) are tumbling after multiple media outlets reported that talks about a takeover of the company by Hasbro (HAS) had ended. WHAT'S NEW: Talks about an acquisition of DreamWorks by Hasbro have ended, multiple news outlets including The Wall Street Journal and Deadline reported over the weekend. However, Deadline, citing unnamed sources, reported that there's "still a slight chance" that the talks will resume. Hasbro's CEO and board visited DreamWorks' campus recently and a potential name for the combined entity - DreamWorks-Hasbro - was discussed, Deadline stated. Hasbro halted the talks because it became concerned about the negative reaction of its stock to reports about the discussions, Deadline added. Barron's weighed in on the issue over the weekend, writing that the deal "doesn't make sense economically." Partnering with DreamWorks would be logical for Habro, but buying DreamWorks would not be a good move for the toy maker, Barron's stated. DreamWorks' recent inability to create big hits or generate free cash makes it a poor takeover target for Hasbro, Barron's indicated. WHAT'S NOTABLE: In a note to investors on Thursday, Sterne Agee analyst Vasily Karasyov wrote that there is "no industrial logic" whatsoever to a combination of DreamWorks and Hasbro. Karasyov said there was no good reason for Hasbro to buy DreamWorks for $35 per share, the price that the movie maker was seeking, according to some reports. Karasyov predicted that the deal would not occur and kept a $17 price target and Underperform rating on the shares. Additionally, Piper Jaffray said the possible acquisition of DreamWorks Animation by Hasbro could have impacted the latter company's partnership with Disney (DIS). Piper thought buying a competing animation company could alter Disney's view of Hasbro as a partner. PRICE ACTION: In early trading, DreamWorks fell 15% to $22.08, while Hasbro gained 4.3% to $56.33.
09:22 EDTHASOn The Fly: Pre-market Movers
Subscribe for More Information
November 16, 2014
18:05 EDTHASHasbro buyout of DreamWorks Animation 'doesn't make sense', Barron's says
Subscribe for More Information
November 15, 2014
08:28 EDTHASHasbro ends DreamWorks talks after stock decline, Deadline reports
Subscribe for More Information
08:25 EDTHASHasbro, DreamWorks talks 'cool,' unlikely to resume, WSJ reports
Hasbro's (HAS) talks to acquire DreamWorks Animation (DWA) have "cooled" and are unlikely to resume, Wall Street Journal reported last night, citing a person familiar with the matter. Reference Link
November 14, 2014
16:26 EDTHASNasdaq clear leader as major averages end week higher
Subscribe for More Information
06:37 EDTHASDreamWorks competes with key Hasbro partner Disney, NY Times says
After multiple news outlets reported that Hasbro (HAS) was in talks about buying DreamWorks (DWA), The New York Times says that the toy maker holds very lucrative contracts with Disney (DIS), which views DreamWorks as a key competitor. Hasbro gets up to 30% of its revenue from products linked to Disney, the newspaper quoted some analysts as saying. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use